恒基达鑫(002492) - 2023 Q3 - 季度财报

Financial Performance - Q3 2023 revenue was CNY 98,385,909.11, a decrease of 3.14% compared to the same period last year[8] - Net profit attributable to shareholders was CNY 30,210,092.10, down 21.07% year-on-year[8] - Net profit excluding non-recurring gains and losses was CNY 28,304,396.24, a decline of 26.98% compared to the previous year[8] - Basic earnings per share for Q3 2023 was CNY 0.0746, down 21.06% year-on-year[8] - The net profit for Q3 2023 was CNY 87,961,197, a decrease of 9.1% compared to CNY 97,731,243 in Q3 2022[26] - The total profit for the period was CNY 103,149,502, down 10.9% from CNY 115,782,078 in the same quarter last year[26] - Operating profit for Q3 2023 was CNY 103,689,968, a decline of 10.7% from CNY 116,178,373 in Q3 2022[26] - The company experienced a decrease in total comprehensive income, which was CNY 72,229,306, compared to CNY 104,470,680 in the same quarter last year[26] Cash Flow and Liquidity - Operating cash flow for the year-to-date reached CNY 282,955,158.23, an increase of 237.65%[8] - The company reported a significant increase in cash flow from operating activities, indicating improved liquidity[8] - The company's cash and cash equivalents rose to CNY 248,721,667.95 from CNY 187,931,472.84, marking an increase of approximately 32.3%[18] - Cash and cash equivalents at the end of the period totaled CNY 245,603,752, compared to CNY 242,348,069 at the end of Q3 2022[29] - The cash inflow from operating activities was CNY 2,076,140,008, down from CNY 2,454,633,777 in Q3 2022[28] - The cash outflow from investing activities was CNY 1,670,392,881, compared to CNY 857,474,550 in the previous year[29] - The net cash flow from financing activities was negative at CNY -20,931,745, an improvement from CNY -94,040,514 in Q3 2022[29] Assets and Liabilities - Total assets at the end of Q3 2023 were CNY 2,044,000,694.86, an increase of 4.79% from the end of the previous year[8] - The total liabilities increased to CNY 375,853,716.93 from CNY 323,939,512.61, reflecting a growth of about 16.0%[20] - Shareholders' equity attributable to the parent company was CNY 1,651,672,435.46, up 2.46% from the previous year-end[8] - The company's equity attributable to shareholders reached CNY 1,651,672,435.46, compared to CNY 1,611,978,114.04, indicating an increase of approximately 2.5%[22] Operational Highlights - Operating costs increased to CNY 200,077,010.16 from CNY 181,927,877.13, representing an increase of approximately 9.5% year-over-year[24] - Research and development expenses for the quarter were CNY 13,340,346.93, slightly up from CNY 13,093,489.97, reflecting a year-over-year increase of about 1.9%[24] - Non-recurring gains and losses for Q3 2023 totaled CNY 1,905,695.86, compared to CNY 8,288,412.89 for the year-to-date[9] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 20,834[15] - The largest shareholder, Zhuhai Shiyou Chemical Co., Ltd., holds 41.40% of the shares, totaling 167,690,000 shares[15] Market Outlook - The decline in net profit and revenue highlights challenges in the current market environment[8] - The company plans to continue expanding its market presence and investing in new technologies to enhance operational efficiency and drive future growth[21]